Nuvectis Pharma to participate in Maxim Growth Summit 2026 panel discussion

NVCT•2026-10-09

Nuvectis Pharma will participate in the Maxim Growth Summit 2026 in New York on Oct. 14, 2026. CEO Ron Bentsur is scheduled to join an Immunology & Inflammation Therapies panel at 10:30 a.m. ET.

1. Summit participation

Nuvectis Pharma will participate in the Maxim Growth Summit 2026 in New York on Oct. 14, 2026. Chairman and CEO Ron Bentsur is scheduled to join an “Immunology & Inflammation Therapies” panel at 10:30 a.m. ET.

Nuvectis Pharma to participate in Maxim Growth Summit 2026 panel discussion

1. Summit participation

Related News

PNC to redeem $1.25 billion of senior notes on Oct. 20, 2026

China AI developers publish safety tests for just 3.6% of model releases, report finds

Harley-Davidson to report third-quarter 2026 results and host webcast call

Canada loses net 68,300 jobs in September, jobless rate rises to 6.5%

Royalty Pharma to report Q3 2026 results, host conference call and webcast